Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 334

1.

Correction to: Recommendations for the management of rheumatoid arthritis in the Eastern Mediterranean region: an adolopment of the 2015 American College of Rheumatology guidelines.

Arayssi T, Harfouche M, Darzi A, Al Emadi S, Alnaqbi KA, Badsha H, Al Balushi F, Dib C, Elzorkany B, Halabi H, Hammoudeh M, Hazer W, Masri B, Merashli M, Omair M, Salloum N, Uthman I, Zahirovic S, Ziade N, Bannuru RR, McAlindon T, Nomier MA, Singh JA, Christensen R, Tugwell P, Schünemann H, Akl EA.

Clin Rheumatol. 2018 Sep 6. doi: 10.1007/s10067-018-4282-0. [Epub ahead of print]

PMID:
30191420
2.

PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation.

Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Stewart L, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, Godfrey CM, Macdonald MT, Langlois EV, Soares-Weiser K, Moriarty J, Clifford T, Tunçalp Ö, Straus SE.

Ann Intern Med. 2018 Sep 4. doi: 10.7326/M18-0850. [Epub ahead of print]

PMID:
30178033
3.

Barriers and facilitators to implementation of essential health benefits package within primary health care settings in low-income and middle-income countries: A systematic review.

El-Jardali F, Fadlallah R, Daouk A, Rizk R, Hemadi N, El Kebbi O, Farha A, Akl EA.

Int J Health Plann Manage. 2018 Aug 22. doi: 10.1002/hpm.2625. [Epub ahead of print] Review.

PMID:
30132987
4.

Financial conflicts of interest in clinical research.

Savović J, Akl EA, Hróbjartsson A.

Intensive Care Med. 2018 Aug 20. doi: 10.1007/s00134-018-5333-3. [Epub ahead of print] No abstract available.

PMID:
30128588
5.

The reporting of funding in health policy and systems research: a cross-sectional study.

Khamis AM, Bou-Karroum L, Hakoum MB, Al-Gibbawi M, Habib JR, El-Jardali F, Akl EA.

Health Res Policy Syst. 2018 Aug 17;16(1):83. doi: 10.1186/s12961-018-0356-3.

6.

Recommendations for the management of rheumatoid arthritis in the Eastern Mediterranean region: an adolopment of the 2015 American College of Rheumatology guidelines.

Arayssi T, Harfouche M, Darzi A, Al Emadi S, A Alnaqbi K, Badsha H, Al Balushi F, Dib C, Elzorkany B, Halabi H, Hammoudeh M, Hazer W, Masri B, Merashli M, Omair M, Salloum N, Uthman I, Zahirovic S, Ziade N, Bannuru RR, McAlindon T, Nomier MA, Singh JA, Christensen R, Tugwell P, Schünemann H, Akl EA.

Clin Rheumatol. 2018 Aug 10. doi: 10.1007/s10067-018-4245-5. [Epub ahead of print] Erratum in: Clin Rheumatol. 2018 Sep 6;:.

PMID:
30097896
7.

The Effectiveness and Cost-Effectiveness of Screening for HIV in Migrants in the EU/EEA: A Systematic Review.

Pottie K, Lotfi T, Kilzar L, Howeiss P, Rizk N, Akl EA, Dias S, Biggs BA, Christensen R, Rahman P, Magwood O, Tran A, Rowbotham N, Pharris A, Noori T, Pareek M, Morton R.

Int J Environ Res Public Health. 2018 Aug 9;15(8). pii: E1700. doi: 10.3390/ijerph15081700. Review.

8.

Reporting of Financial and Non-financial Conflicts of Interest in Systematic Reviews on Health Policy and Systems Research: A Cross Sectional Survey.

Bou-Karroum L, Hakoum MB, Hammoud MZ, Khamis AM, Al-Gibbawi M, Badour S, Justina Hasbani D, Cruz Lopes L, El-Rayess HM, El-Jardali F, Guyatt G, Akl EA.

Int J Health Policy Manag. 2018 Feb 12;7(8):711-717. doi: 10.15171/ijhpm.2017.146.

9.

Using systematic reviews in guideline development: the GRADE approach.

Zhang Y, Akl EA, Schünemann HJ.

Res Synth Methods. 2018 Jul 14. doi: 10.1002/jrsm.1313. [Epub ahead of print]

PMID:
30006970
10.

Development of rapid guidelines: 3. GIN-McMaster Guideline Development Checklist extension for rapid recommendations.

Morgan RL, Florez I, Falavigna M, Kowalski S, Akl EA, Thayer KA, Rooney A, Schünemann HJ.

Health Res Policy Syst. 2018 Jul 13;16(1):63. doi: 10.1186/s12961-018-0330-0.

11.

Anticoagulation for perioperative thromboprophylaxis in people with cancer.

Matar CF, Kahale LA, Hakoum MB, Tsolakian IG, Etxeandia-Ikobaltzeta I, Yosuico VE, Terrenato I, Sperati F, Barba M, Schünemann H, Akl EA.

Cochrane Database Syst Rev. 2018 Jul 11;7:CD009447. doi: 10.1002/14651858.CD009447.pub3. Review.

PMID:
29993117
12.

McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome.

Legault K, Schunemann H, Hillis C, Yeung C, Akl EA, Carrier M, Cervera R, Crowther M, Dentali F, Erkan D, Espinosa G, Khamashta M, Meerpohl JJ, Moffat K, O'Brien S, Pengo V, Rand JH, Rodriguez Pinto I, Thom L, Iorio A.

J Thromb Haemost. 2018 Jun 7. doi: 10.1111/jth.14192. [Epub ahead of print]

PMID:
29978552
13.

Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.

Kahale LA, Hakoum MB, Tsolakian IG, Matar CF, Terrenato I, Sperati F, Barba M, Yosuico VE, Schünemann H, Akl EA.

Cochrane Database Syst Rev. 2018 Jun 19;6:CD006650. doi: 10.1002/14651858.CD006650.pub5. Review.

PMID:
29920657
14.

Anticoagulation for people with cancer and central venous catheters.

Kahale LA, Tsolakian IG, Hakoum MB, Matar CF, Barba M, Yosuico VE, Terrenato I, Sperati F, Schünemann H, Akl EA.

Cochrane Database Syst Rev. 2018 Jun 1;6:CD006468. doi: 10.1002/14651858.CD006468.pub6. Review.

PMID:
29856471
15.

GRADE guidelines: 20. Assessing the certainty of evidence in the importance of outcomes or values and preferences-inconsistency, imprecision, and other domains.

Zhang Y, Coello PA, Guyatt GH, Yepes-Nuñez JJ, Akl EA, Hazlewood G, Pardo-Hernandez H, Etxeandia-Ikobaltzeta I, Qaseem A, Williams JW Jr, Tugwell P, Flottorp S, Chang Y, Zhang Y, Mustafa RA, Rojas MX, Xie F, Schünemann HJ.

J Clin Epidemiol. 2018 May 22. pii: S0895-4356(17)31061-2. doi: 10.1016/j.jclinepi.2018.05.011. [Epub ahead of print]

PMID:
29800687
16.

Prophylactic Cranial Irradiation in Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Al Feghali KA, Ballout RA, Khamis AM, Akl EA, Geara FB.

Front Oncol. 2018 Apr 20;8:115. doi: 10.3389/fonc.2018.00115. eCollection 2018.

17.

Public health journals' requirements for authors to disclose funding and conflicts of interest: a cross-sectional study.

Daou KN, Hakoum MB, Khamis AM, Bou-Karroum L, Ali A, Habib JR, Semaan AT, Guyatt G, Akl EA.

BMC Public Health. 2018 Apr 23;18(1):533. doi: 10.1186/s12889-018-5456-z.

18.

Authorship in reports of clinical practice guidelines: A systematic cross-sectional analysis.

Nomier M, Khamis AM, Ali A, Daou KN, Semaan AT, Diab M, Akl EA.

Int J Clin Pract. 2018 Jul;72(7):e13083. doi: 10.1111/ijcp.13083. Epub 2018 Apr 17.

PMID:
29665199
19.

Do clinicians want recommendations? A multicenter study comparing evidence summaries with and without GRADE recommendations.

Neumann I, Alonso-Coello P, Vandvik PO, Agoritsas T, Mas G, Akl EA, Brignardello-Petersen R, Emparanza J, McCullagh L, De Sitio C, McGinn T, Almodaimegh H, Almodaimegh K, Rivera S, Rojas L, Stirnemann J, Irani J, Hlais S, Mustafa R, Bdair F, Aly A, Kristiansen A, Izcovich A, Ramirez A, Brozek J, Guyatt G, Schünemann HJ.

J Clin Epidemiol. 2018 Jul;99:33-40. doi: 10.1016/j.jclinepi.2018.02.026. Epub 2018 Mar 9.

PMID:
29530644
20.

Systematic reviews do not adequately report or address missing outcome data in their analyses: a methodological survey.

Kahale LA, Diab B, Brignardello-Petersen R, Agarwal A, Mustafa RA, Kwong J, Neumann I, Li L, Lopes LC, Briel M, Busse JW, Iorio A, Vandvik PO, Alexander PE, Guyatt G, Akl EA.

J Clin Epidemiol. 2018 Jul;99:14-23. doi: 10.1016/j.jclinepi.2018.02.016. Epub 2018 Mar 2. Review.

PMID:
29505859
21.

GRADE Guidelines: 19. Assessing the certainty of evidence in the importance of outcomes or values and preferences-Risk of bias and indirectness.

Zhang Y, Alonso-Coello P, Guyatt GH, Yepes-Nuñez JJ, Akl EA, Hazlewood G, Pardo-Hernandez H, Etxeandia-Ikobaltzeta I, Qaseem A, Williams JW Jr, Tugwell P, Flottorp S, Chang Y, Zhang Y, Mustafa RA, Rojas MX, Schünemann HJ.

J Clin Epidemiol. 2018 Feb 13. pii: S0895-4356(17)31036-3. doi: 10.1016/j.jclinepi.2018.01.013. [Epub ahead of print]

PMID:
29452223
22.

GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence.

Schünemann HJ, Cuello C, Akl EA, Mustafa RA, Meerpohl JJ, Thayer K, Morgan RL, Gartlehner G, Kunz R, Katikireddi SV, Sterne J, Higgins JP, Guyatt G; GRADE Working Group.

J Clin Epidemiol. 2018 Feb 9. pii: S0895-4356(17)31031-4. doi: 10.1016/j.jclinepi.2018.01.012. [Epub ahead of print]

PMID:
29432858
23.

The prevalence and trends of waterpipe tobacco smoking: A systematic review.

Jawad M, Charide R, Waziry R, Darzi A, Ballout RA, Akl EA.

PLoS One. 2018 Feb 9;13(2):e0192191. doi: 10.1371/journal.pone.0192191. eCollection 2018. Review.

24.

Barriers and facilitators to implementation, uptake and sustainability of community-based health insurance schemes in low- and middle-income countries: a systematic review.

Fadlallah R, El-Jardali F, Hemadi N, Morsi RZ, Abou Samra CA, Ahmad A, Arif K, Hishi L, Honein-AbouHaidar G, Akl EA.

Int J Equity Health. 2018 Jan 29;17(1):13. doi: 10.1186/s12939-018-0721-4. Review.

25.

Anticoagulation for the initial treatment of venous thromboembolism in people with cancer.

Hakoum MB, Kahale LA, Tsolakian IG, Matar CF, Yosuico VE, Terrenato I, Sperati F, Barba M, Schünemann H, Akl EA.

Cochrane Database Syst Rev. 2018 Jan 24;1:CD006649. doi: 10.1002/14651858.CD006649.pub7. Review.

PMID:
29363105
26.

Methods used in adaptation of health-related guidelines: A systematic survey.

Abdul-Khalek RA, Darzi AJ, Godah MW, Kilzar L, Lakis C, Agarwal A, Abou-Jaoude E, Meerpohl JJ, Wiercioch W, Santesso N, Brax H, Schünemann H, Akl EA.

J Glob Health. 2017 Dec;7(2):020412. doi: 10.7189/jogh.07.020412. Review.

27.

Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation.

Kahale LA, Hakoum MB, Tsolakian IG, Matar CF, Barba M, Yosuico VED, Terrenato I, Sperati F, Schünemann H, Akl EA.

Cochrane Database Syst Rev. 2017 Dec 29;12:CD006466. doi: 10.1002/14651858.CD006466.pub6. Review.

PMID:
29285754
28.

Extent of physician-pharmaceutical industry interactions in low- and middle-income countries: a systematic review.

Fadlallah R, Alkhaled L, Brax H, Nasser M, Rajabbik MH, Nass H, Kahale LA, Akl EA.

Eur J Public Health. 2018 Apr 1;28(2):224-230. doi: 10.1093/eurpub/ckx204.

PMID:
29165586
29.

[A reporting tool for practice guidelines in health care: the RIGHT statement].

Chen Y, Yang K, Marušić A, Qaseem A, Meerpohl JJ, Flottorp S, Akl EA, Schünemann HJ, Chan ESY, Falck-Ytter Y, Ahmed F, Barber S, Chen C, Zhang M, Xu B, Tian J, Song F, Shang H, Tang K, Wang Q, Norris SL; RIGHT (Reporting Items for Practice Guidelines in Healthcare) Working Group, Labonté VC, Möhler R, Kopp I, Nothacker M, Meerpohl JJ.

Z Evid Fortbild Qual Gesundhwes. 2017 Nov;127-128:3-10. doi: 10.1016/j.zefq.2017.10.008. Epub 2017 Nov 9. German.

PMID:
29128430
30.

Considering health equity when moving from evidence-based guideline recommendations to implementation: a case study from an uppermiddle income country on the GRADE approach.

Eslava-Schmalbach J, Mosquera P, Alzate JP, Pottie K, Welch V, Akl EA, Jull J, Lang E, Katikireddi SV, Morton R, Thabane L, Shea B, Stein AT, Singh J, Florez ID, Guyatt G, Schünemann H, Tugwell P.

Health Policy Plan. 2017 Dec 1;32(10):1492. doi: 10.1093/heapol/czx158. No abstract available.

PMID:
29117368
31.

Correction to: Adaptation of the 2015 American College of Rheumatology treatment guideline for rheumatoid arthritis for the Eastern Mediterranean Region: an exemplar of the GRADE Adolopment.

Darzi A, Harfouche M, Arayssi T, Alemadi S, Alnaqbi KA, Badsha H, Al Balushi F, Elzorkany B, Halabi H, Hamoudeh M, Hazer W, Masri B, Omair MA, Uthman I, Ziade N, Singh JA, Christiansen R, Tugwell P, Schünemann HJ, Akl EA.

Health Qual Life Outcomes. 2017 Oct 26;15(1):214. doi: 10.1186/s12955-017-0791-9. No abstract available.

32.

Considering health equity when moving from evidence-based guideline recommendations to implementation: a case study from an upper-middle income country on the GRADE approach.

Eslava-Schmalbach J, Mosquera P, Alzate JP, Pottie K, Welch V, Akl EA, Jull J, Lang E, Katikireddi SV, Morton R, Thabane L, Shea B, Stein AT, Singh J, Florez ID, Guyatt G, Schünemann H, Tugwell P.

Health Policy Plan. 2017 Dec 1;32(10):1484-1490. doi: 10.1093/heapol/czx126.

33.

Characteristics of funding of clinical trials: cross-sectional survey and proposed guidance.

Hakoum MB, Jouni N, Abou-Jaoude EA, Hasbani DJ, Abou-Jaoude EA, Lopes LC, Khaldieh M, Hammoud MZ, Al-Gibbawi M, Anouti S, Guyatt G, Akl EA.

BMJ Open. 2017 Oct 5;7(10):e015997. doi: 10.1136/bmjopen-2017-015997.

34.

Adaptation of the 2015 American College of Rheumatology treatment guideline for rheumatoid arthritis for the Eastern Mediterranean Region: an exemplar of the GRADE Adolopment.

Darzi A, Harfouche M, Arayssi T, Alemadi S, Alnaqbi KA, Badsha H, Al Balushi F, Elzorkany B, Halabi H, Hamoudeh M, Hazer W, Masri B, Omair MA, Uthman I, Ziade N, Singh JA, Christiansen R, Tugwell P, Schünemann HJ, Akl EA.

Health Qual Life Outcomes. 2017 Sep 21;15(1):183. doi: 10.1186/s12955-017-0754-1. Erratum in: Health Qual Life Outcomes. 2017 Oct 26;15(1):214.

35.

Requirements of health policy and services journals for authors to disclose financial and non-financial conflicts of interest: a cross-sectional study.

Khamis AM, Hakoum MB, Bou-Karroum L, Habib JR, Ali A, Guyatt G, El-Jardali F, Akl EA.

Health Res Policy Syst. 2017 Sep 19;15(1):80. doi: 10.1186/s12961-017-0244-2.

36.

[GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines].

Alonso-Coello P, Oxman AD, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, Treweek S, Mustafa RA, Vandvik PO, Meerpohl J, Guyatt GH, Schünemann HJ; el GRADE Working Group.

Gac Sanit. 2018 Mar - Apr;32(2):167.e1-167.e10. doi: 10.1016/j.gaceta.2017.03.008. Epub 2017 Sep 13. Spanish.

37.

Living systematic review: 1. Introduction-the why, what, when, and how.

Elliott JH, Synnot A, Turner T, Simmonds M, Akl EA, McDonald S, Salanti G, Meerpohl J, MacLehose H, Hilton J, Tovey D, Shemilt I, Thomas J; Living Systematic Review Network.

J Clin Epidemiol. 2017 Nov;91:23-30. doi: 10.1016/j.jclinepi.2017.08.010. Epub 2017 Sep 11.

PMID:
28912002
38.

Living systematic reviews: 4. Living guideline recommendations.

Akl EA, Meerpohl JJ, Elliott J, Kahale LA, Schünemann HJ; Living Systematic Review Network.

J Clin Epidemiol. 2017 Nov;91:47-53. doi: 10.1016/j.jclinepi.2017.08.009. Epub 2017 Sep 11. Review.

PMID:
28911999
39.

Characterizing the interaction between physicians, pharmacists and pharmaceutical representatives in a middle-income country: A qualitative study.

Hajjar R, Bassatne A, Cheaito MA, Naser El Dine R, Traboulsy S, Haddadin F, Honein-AbouHaidar G, Akl EA.

PLoS One. 2017 Sep 12;12(9):e0184662. doi: 10.1371/journal.pone.0184662. eCollection 2017.

40.

Prevention and assessment of infectious diseases among children and adult migrants arriving to the European Union/European Economic Association: a protocol for a suite of systematic reviews for public health and health systems.

Pottie K, Mayhew AD, Morton RL, Greenaway C, Akl EA, Rahman P, Zenner D, Pareek M, Tugwell P, Welch V, Meerpohl J, Alonso-Coello P, Hui C, Biggs BA, Requena-Méndez A, Agbata E, Noori T, Schünemann HJ.

BMJ Open. 2017 Sep 11;7(9):e014608. doi: 10.1136/bmjopen-2016-014608. Review.

41.

Parenteral anticoagulation in ambulatory patients with cancer.

Akl EA, Kahale LA, Hakoum MB, Matar CF, Sperati F, Barba M, Yosuico VED, Terrenato I, Synnot A, Schünemann H.

Cochrane Database Syst Rev. 2017 Sep 11;9:CD006652. doi: 10.1002/14651858.CD006652.pub5. Review.

PMID:
28892556
42.

The SPARK Tool to prioritise questions for systematic reviews in health policy and systems research: development and initial validation.

Akl EA, Fadlallah R, Ghandour L, Kdouh O, Langlois E, Lavis JN, Schünemann H, El-Jardali F.

Health Res Policy Syst. 2017 Sep 4;15(1):77. doi: 10.1186/s12961-017-0242-4.

43.

[GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction].

Alonso-Coello P, Schünemann HJ, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, Treweek S, Mustafa RA, Rada G, Rosenbaum S, Morelli A, Guyatt GH, Oxman AD; el GRADE Working Group.

Gac Sanit. 2018 Mar - Apr;32(2):166.e1-166.e10. doi: 10.1016/j.gaceta.2017.02.010. Epub 2017 Aug 17. Spanish.

44.

GRADE equity guidelines 4: considering health equity in GRADE guideline development: evidence to decision process.

Pottie K, Welch V, Morton R, Akl EA, Eslava-Schmalbach JH, Katikireddi V, Singh J, Moja L, Lang E, Magrini N, Thabane L, Stanev R, Matovinovic E, Snellman A, Briel M, Shea B, Tugwell P, Schunemann H, Guyatt G, Alonso-Coello P.

J Clin Epidemiol. 2017 Oct;90:84-91. doi: 10.1016/j.jclinepi.2017.08.001. Epub 2017 Aug 10.

PMID:
28802675
45.

Waterpipe product packaging and labelling at the 3rd international Hookah Fair; does it comply with Article 11 of the Framework Convention on Tobacco Control?

Jawad M, Darzi A, Lotfi T, Nakkash R, Hawkins B, Akl EA.

J Public Health Policy. 2017 Aug;38(3):303-313. doi: 10.1057/s41271-017-0078-8.

46.

A systematic survey on reporting and methods for handling missing participant data for continuous outcomes in randomized controlled trials.

Zhang Y, Flórez ID, Colunga Lozano LE, Aloweni FAB, Kennedy SA, Li A, Craigie S, Zhang S, Agarwal A, Lopes LC, Devji T, Wiercioch W, Riva JJ, Wang M, Jin X, Fei Y, Alexander P, Morgano GP, Zhang Y, Carrasco-Labra A, Kahale LA, Akl EA, Schünemann HJ, Thabane L, Guyatt GH.

J Clin Epidemiol. 2017 Aug;88:57-66. doi: 10.1016/j.jclinepi.2017.05.017. Epub 2017 Jun 3. Review.

PMID:
28583378
47.

A systematic survey of the methods literature on the reporting quality and optimal methods of handling participants with missing outcome data for continuous outcomes in randomized controlled trials.

Zhang Y, Alyass A, Vanniyasingam T, Sadeghirad B, Flórez ID, Pichika SC, Kennedy SA, Abdulkarimova U, Zhang Y, Iljon T, Morgano GP, Colunga Lozano LE, Aloweni FAB, Lopes LC, Yepes-Nuñez JJ, Fei Y, Wang L, Kahale LA, Meyre D, Akl EA, Thabane L, Guyatt GH.

J Clin Epidemiol. 2017 Aug;88:67-80. doi: 10.1016/j.jclinepi.2017.05.016. Epub 2017 Jun 1. Review.

PMID:
28579378
48.

CMV and BKPyV Infections in Renal Transplant Recipients Receiving an mTOR Inhibitor-Based Regimen Versus a CNI-Based Regimen: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials.

Mallat SG, Tanios BY, Itani HS, Lotfi T, McMullan C, Gabardi S, Akl EA, Azzi JR.

Clin J Am Soc Nephrol. 2017 Aug 7;12(8):1321-1336. doi: 10.2215/CJN.13221216. Epub 2017 Jun 2. Review.

49.

GRADE guidelines 17: assessing the risk of bias associated with missing participant outcome data in a body of evidence.

Guyatt GH, Ebrahim S, Alonso-Coello P, Johnston BC, Mathioudakis AG, Briel M, Mustafa RA, Sun X, Walter SD, Heels-Ansdell D, Neumann I, Kahale LA, Iorio A, Meerpohl J, Schünemann HJ, Akl EA.

J Clin Epidemiol. 2017 Jul;87:14-22. doi: 10.1016/j.jclinepi.2017.05.005. Epub 2017 May 18.

PMID:
28529188
50.

The GRADE Working Group clarifies the construct of certainty of evidence.

Hultcrantz M, Rind D, Akl EA, Treweek S, Mustafa RA, Iorio A, Alper BS, Meerpohl JJ, Murad MH, Ansari MT, Katikireddi SV, Östlund P, Tranæus S, Christensen R, Gartlehner G, Brozek J, Izcovich A, Schünemann H, Guyatt G.

J Clin Epidemiol. 2017 Jul;87:4-13. doi: 10.1016/j.jclinepi.2017.05.006. Epub 2017 May 18.

Supplemental Content

Support Center